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Lupus nephritis is believed to result from the forma-
tion of glomerular immune deposits. However, the
mechanisms by which autoantibodies form the im-
mune deposits are still unclear [1], although the
amount and the location of these immune deposits
determine the histologic pattern of lupus nephritis
[2,3]. Focal or diffuse proliferative lupus nephritis are
characterized by deposits in both the glomerular cap-
illary loops and in the mesangial areas [2].
The presence of immune deposits within the suben-
dothelial space of glomerular capillary loops appears
to be critical for the induction of severe glomerular
injury in systemic lupus erythematosus (SLE) and the
number of subendothelial deposits generally corre-
lates with the degree of intracapillary or extracapil-
lary proliferation and necrosis [4]. It is extremely rare
for patients with diffuse proliferative lupus nephritis
to have little or no subendothelial deposits [3,5,6]. We
report one rare case with diffuse proliferative lupus
nephritis but without comparable amounts of immune
deposits.
CASE PRESENTATION
A 26-year-old Chinese female presented with dyspnea
and bilateral lower extremity edema. Tracing back
her history, she was diagnosed with SLE in March
2005, with an initial presentation of fever, skin rashes,
and bilateral lower extremity edema. Her lupus had
been controlled by prednisolone, but she stopped
medication for 1 week before admission in July 2005.
Physical examination revealed a body temperature of
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A 26-year-old female with systemic lupus erythematosus was admitted because of dyspnea and
progressive lower extremity edema. Laboratory testing showed blood urea nitrogen levels of
147 mg/dL, creatinine of 6.7 mg/dL, serum albumin of 1.7 g/dL and the daily protein loss was
12.7 g. Her C3 level was 60.4 mg/dL and C4 level was 10.2 mg/dL. The antinuclear antibody titer
was 1:320, with a homogeneous pattern, but she was negative for anti-dsDNA. ELISA testing for
anti-PR3 antibodies and anti-MPO antibodies were all negative. She was also negative for circu-
lating lupus anticoagulant. Renal biopsy revealed diffuse proliferation of glomerular cells, but
immunofluorescent microscopy showed no immune deposits and electron microscopy revealed
only scanty electron-dense deposits. She received 1 g/day of methylprednisolone intravenously
for 3 days, followed by 60 mg/day of prednisolone. She was discharged with serum creatinine
decreased to 4.7 mg/dL, and a great improvement in dyspnea. Diffuse proliferative lupus nephritis
that contains little or no subendothelial deposits is rare. The differential diagnosis, possible
mechanisms and treatment are discussed.
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36.6°C, pale appearance, bilateral basilar lung rales
and marked, pitting edema over bilateral lower ex-
tremities. No skin rashes were noted and no oral
ulcer was found. Chest radiography performed at
admission showed bilateral upper lobe infiltrate and
cardiomegaly.
Admission laboratory tests showed hemoglobin
of 4.8 g/dL, hematocrit of 15.5%, white blood cell
count of 6,680/μL, platelet count of 110,000/μL, eryth-
rocyte sedimentation rate of 80 mm/hour, blood urea
nitrogen of 147 mg/dL, creatinine of 6.7 mg/dL, and
serum albumin of 1.7 g/dL. Urinalysis showed 4+
protein and 5–10 red blood cells per high-power
field, and daily protein loss was 12.7 g. Additional
laboratory values included C3 level of 60.4 mg/dL
(reference range, 83.1–125.5 mg/dL), and C4 level of
10.2 mg/dL (reference range, 17.2–32.8 mg/dL). Hap-
toglobin was less than 5.83 mg/dL (reference range,
13–163 mg/dL) with evidence of hemolysis. Antinu-
clear antibody (ANA) titer was 1:320, with a homoge-
neous pattern, but the patient was negative for
anti-dsDNA. ELISA testing for anti-proteinase 3 anti-
bodies and anti-myeloperoxidase antibodies were all
negative. She was negative for a circulating lupus
anticoagulant.
Renal sonography showed 12-cm kidneys with no
hydronephrosis. A renal biopsy was performed on
August 5, 2005, which revealed features of World
Health Organization (WHO) class IV lupus nephritis.
Thereafter, she was given 1 g/day of methylpredniso-
lone intravenously for 3 days, followed by 60 mg/day
of prednisolone. She was discharged on August 23,
2005, with serum creatinine decreased to 4.7 mg/dL,
and a great improvement in dyspnea. However, she
was lost to follow-up 1 week after discharge and
refused further treatment. She died 2 months later.
Renal biopsy findings showed prominent global
hypercellularity and lobulation in a total of nine
glomeruli, and fibrocellular crescents were also present
in all of the glomeruli. There was distinct intracapillary
cell infiltration, but no necrotizing lesion was found.
No feature of thrombotic microangiopathy was iden-
tified. There was also a moderate degree of diffuse
interstitial cell infiltration (Figure 1). Immunofluores-
cence microscopy showed no staining for IgG, IgA,
IgM, C1q, C3 or C4. Electron microscopy revealed only
a scanty amount of subepithelial electron-dense depos-
its. The glomerular basement membrane was not thick-
ened and the foot processes were effaced (Figure 2).
DISCUSSION
We have presented a case of lupus nephritis with his-
tologic features compatible with diffuse proliferative
lupus nephritis (WHO class IV), but immunofluores-
cent microscopy showed no immune deposits and elec-
tron microscopy revealed only scanty electron-dense
Figure 1. Both glomeruli revealed prominent endocapillary
hypercellularity, lobulation, and fibrocellular crescent formation.
Note the interstitial lymphocytic infiltrate (Periodic acid-Schiff,
magnification 400×).
Figure 2. Electron micrograph shows the glomerular capillary loop
and mesangial area with only scanty subepithelial electron-dense
deposits (arrows) (uranyl acetate and lead citrate, magnification
4,000×).
deposits. Such “pauci-immune” diffuse proliferative
lupus nephritis is quite rare [3,5,6].
The most important differential diagnosis for
pauci-immune lupus nephritis is the antineutrophilic
cytoplasmic antibodies (ANCA)-associated pauci-
immune glomerulonephritis occurring in patients
with SLE with minimal renal involvement, especially
when the patients had either normal or only mildly
abnormal serum levels of C3, C4 and anti-dsDNA,
such as the cases reported by Schwartz et al [6]. The
major ANCA-associated pauci-immune glomerulone-
phritis to be considered include Wegener’s granulo-
matosis, microscopic polyangiitis, and renal-limited
microscopic polyangiitis [7]. Characteristics of these
three diseases were not found in our renal specimen
and ELISA test for ANCA was also negative in our
patient. Histologically, Charney et al indicated that
the glomerular feature of pauci-immune lupus nephri-
tis is intracapillary hypercellularity with occasional
crescents, rather than necrotizing lesions [5]. In con-
trast, ANCA-associated pauci-immune glomerulone-
phritis is characterized by focal segmental necrotizing
glomerulonephritis associated with extracapillary
proliferation of cells in Bowman’s space to form glo-
merular crescents with no or minimal intracapillary
hypercellularity. There is greater disruption of
Bowman’s capsule than in those occurring in immune
complex crescentic glomerulonephritis [5,7,8].
The mechanisms by which the diffuse proliferative
lupus nephritis with scanty immune deposits devel-
oped remain a mystery. Delayed-type hypersensitivity
(DTH) that was reported in ANCA-associated pauci-
immune glomerulonephritis may also be involved.
DTH is a manifestation of cell-mediated immunity
that is induced by sensitized T cells that recruit and
activate macrophages at the site of antigen challenge
[9]. Several studies have shown that sensitized cells
can cause severe glomerular injury, which is inde-
pendent of humoral immune responses, and are likely
to be the principal mediators of crescent formation
[10]. Cunningham et al [9] had found that the glomer-
uli of patients with ANCA-associated pauci-immune
glomerulonephritis exhibit prominent features of
DTH, in combination with the absence of antibody
and complement, which suggests an important path-
ogenic role for cell-mediated immunity. Therefore, 
it becomes an interesting question whether pauci-
immune lupus nephritis is also a manifestation of 
T cell-directed cognate immune injury.
There is no standard treatment for pauci-immune
necrotizing lupus nephritis because cases are rare.
Both of the cases reported by Akhtar et al [3] appar-
ently responded to steroid and cyclophosphamide
treatment. One case received pulse methylpredniso-
lone and six cycles of monthly intravenous cyclophos-
phamide, and the other patient was treated with
prednisone 30 mg/day initially and later maintained
on prednisone and cyclophosphamide. The protocol
of cyclophosphamide was not mentioned. Three of
the five patients presented by Charney et al [5] also
responded to therapy. Two received daily cyclophos-
phamide and prednisone, and one received not only
cyclophosphamide and prednisone but also plasma
exchange. Our patient presented a modest initial
response after high-dose methylprednisolone and
was maintained on prednisolone, although she was
lost to follow-up later. Although clinical experience is
limited, it seems that steroids and cyclophosphamide
are effective in treating pauci-immune lupus nephri-
tis as for regular proliferative lupus nephritis.
In conclusion, pauci-immune lupus nephritis is
extremely rare and testing for ANCA and the differ-
ence in histologic features are helpful to distinguish it
from ANCA-associated pauci-immune glomerulone-
phritis. Although the precise pathogenesis is unclear
and the treatment protocol is not conclusive, evi-
dence suggests that steroids and cyclophosphamide
may be the most effective treatment.
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二十六歲紅斑性狼瘡女性病患因呼吸困難及下肢水腫住院。生化檢查發現血清尿素氮
為 147 mg/dL，肌酸酐為 6.7 mg/dL，每天尿蛋白流失 12.7 公克。血清補體，
C3、C4 皆下降，抗核抗體效價為 1:320，但抗雙鏈 DNA 抗體為陰性。以酵素連結
免疫吸附分析檢查發現 anti-PR3 抗體及 anti-MPO 抗體皆為陰性。血中 lupus 
anticoagulant 亦為陰性。腎臟切片在光學顯微鏡下可發現細胞廣泛增生的腎絲球，
但是螢光顯微鏡檢及電子顯微鏡並無發現任何或僅發現極稀少的免疫沈積。患者接受
甲基類固醇脈衝治療，每天 1 公克注射 3 天後，維持口服類固醇每天 60 毫克治療。
出院時腎功能及呼吸困難皆獲得改善。廣泛增生性狼瘡腎炎卻僅能發現極少，甚至沒
有免疫沈積的情形非常少見。本文在此討論此罕見病例的鑑別診斷，可能的機轉以及
治療方式。
關鍵詞：新月型腎絲球腎炎，狼瘡腎炎，稀少免疫沈積腎絲球腎炎，紅斑性狼瘡
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